For the purposes of this Privacy Policy the references to ‘you’ shall mean any natural person whose data is being processed by us, Trichem Healthcare Private Limited, Trichem Lifesciences Limited and Trichem (We/ Us/ Trichem). Our services include indenting, distribution and manufacturing of active pharmaceutical ingredients, bulk drugs and intermediates (Services).
This Privacy Policy explains our practices regarding the processing of personal data we collect from you. This Privacy Policy applies to all Services offered by Us including through the website www.tricheminc.net (Platform). This Privacy Policy applies to all persons accessing the Platform (Users). This Privacy Policy is to be read in conjunction with the Terms & Conditions accessible at: https://tricheminc.net/terms-and-condition/ and any other agreement executed between you and Us.
We collect and process your personal data only in terms of this Privacy Policy. Personal data means any data about a User who is identifiable by or in relation to such data.
BY USING THE PLATFORM, YOU HEREBY PROVIDE YOUR FREE AND INFORMED CONSENT TO THE PROCESSING OF YOUR PERSONAL DATA AND AGREE TO THE STIPULATIONS OF THIS POLICY. IF YOU DO NOT AGREE WITH THE STIPULATIONS OF THIS POLICY, YOU ARE REQUESTED TO IMMEDIATELY CEASE YOUR ACCESS TO AND USE OF THE PLATFORM. TRICHEM RESERVES THE RIGHT TO RESTRICT YOUR ACCESS TO THE PLATFORM IF YOU DO NOT ACCEPT ALL STIPULATIONS OF THE PRIVACY POLICY.
If the User is a minor, or a person with a disability, the parent/ guardian as the case may be, must provide their free and informed consent to all stipulations of this Privacy Policy on behalf of the User, failing which the User should not access the Platform for any reason whatsoever.
SECURITY OF YOUR INFORMATION
DATA RETENTION
Vinita Gehnani
This policy was last updated on 07th June, 2025.
API's | CAS Number | Country of Origin | RC no | Valid Upto |
---|---|---|---|---|
Clindamycin HCl IP/BP/EP /USP | 21462-39-5 | China | BD-316 | 19-Sep-24 |
Clindamycin Phosphate IP/USP | 24729-96-2 | China | BD-316 | 19-Sep-24 |
Topotecan HCl | 119413-54-6 | Taiwan | BD-002212 | 5-Mar-24 |
Docetaxel Anhydrous IP | 114977-28-5 | Taiwan | BD-002212 | 5-Mar-24 |
Azacitidine IP | 320-67-2 | Taiwan | BD-002212 | 5-Mar-24 |
Paclitaxel IP | 33069-62-4 | Taiwan | BD-002235 | 26-Dec-24 |
Galantamine HBr IP | 1953-04-4 | Taiwan | BD-002235 | 26-Dec-24 |
Irinotecan HCl Trihydrate IP | 136572-09-3 | Taiwan | BD-002235 | 26-Dec-24 |
Gemcitabine HCl IP | 122111-03-9 | Taiwan | BD-002235 | 26-Dec-24 |
Doxorubicin HCl IP | 25316-40-9 | Germany | BD-002524 | 1-Jul-24 |
Epirubicin HCl EP | 56390-09-1 | Germany | BD-002524 | 1-Jul-24 |
Mometasone Furoate IP | 83919-23-7 | Italy | BD-002426 | Under Renewal |
Moxonidine micronized EP (non-sterile) | 75438-57-2 | Czech Republic | BD-1036 | 20-Jun-24 |
Alfuzosin HCl IP | 81403-68-1 | Czech Republic | BD-1036 | 20-Jun-24 |
Tacrolimus IP/USP | 104987-11-3 | Taiwan | 002671 | 29-May-26 |
CAS No : 13171-25-0
Molecular formula : C14H22N2O3, 2HCl
Molecular weight : 339.3
Category : Antianginal Drug
CAS No : 95635-55-5
Molecular formula : C24H33N3O4
Molecular weight : 427.536
Category : Antianginal Drug
CAS No : 77-36-1
Molecular formula : C14H11CLN2O4S
Molecular weight : 338.76
Category : Diuretic Drug